Reproductive Pathology — MCQs
On this page
A 27-year-old female feels a lump in her breast and schedules an appointment with her doctor for examination. A tissue biopsy is taken and examined, with multiple areas showing only benign features. Which of the following findings implies an increased risk of subsequently developing invasive carcinoma?
Serum alpha-fetoprotein level is elevated in which of the following conditions?
Which virus is associated with cancer of the cervix?
Fibrocystic disease of the breast is associated with which hormonal imbalance?
A 22-year-old man complains about his inability to conceive a child. On physical examination, the patient is noted to be tall (6 ft, 5 in) and exhibits gynecomastia and testicular atrophy. Laboratory studies demonstrate increased serum levels of follicle-stimulating hormone. Cytogenetic studies reveal a chromosomal abnormality. What is the most common cause of this patient's chromosomal abnormality?
What is the tumor marker for choriocarcinoma?
Struma ovarii is composed entirely of what tissue?
Infertility in Kallmann syndrome is due to?
A 29-year-old female presents with severe pain during menstruation (dysmenorrhea). During workup, an endometrial biopsy is obtained. The pathology report from this specimen makes the diagnosis of chronic endometritis. Based on this pathology report, which one of the following was present in the biopsy sample of the endometrium?
Benign condyloma is associated with which condition?
Reproductive Pathology Indian Medical PG Practice Questions and MCQs
Question 51: A 27-year-old female feels a lump in her breast and schedules an appointment with her doctor for examination. A tissue biopsy is taken and examined, with multiple areas showing only benign features. Which of the following findings implies an increased risk of subsequently developing invasive carcinoma?
- A. Apocrine metaplasia
- B. Blue-domed cysts of Bloodgood
- C. Duct ectasia
- D. Sclerosing adenosis (Correct Answer)
Explanation: This question tests your ability to categorize benign breast lesions based on their risk of progression to invasive carcinoma. ### **Explanation of the Correct Answer** **Sclerosing adenosis** is classified as a **Proliferative Breast Disease without atypia** [1]. Histologically, it is characterized by an increased number of acini (adenosis) and stromal fibrosis (sclerosis) that compresses the lumens [2]. While benign, it is associated with a **1.5 to 2-fold (slightly increased) risk** of developing invasive carcinoma in either breast [1]. It often presents as a palpable mass or radiologic calcifications, mimicking malignancy [2]. ### **Analysis of Incorrect Options** * **A & B: Apocrine Metaplasia and Blue-domed cysts:** These are features of **Non-proliferative Breast Changes** (Fibrocystic changes). Apocrine metaplasia (columnar cells with granular eosinophilic cytoplasm) and cysts (like the "Blue-domed cysts of Bloodgood") carry **no increased risk** (Relative Risk = 1.0) for malignancy. * **C: Duct ectasia:** This is an inflammatory condition characterized by the dilation of large ducts and periductal inflammation, typically in multiparous women. It is **not associated** with an increased risk of cancer. ### **NEET-PG High-Yield Pearls** To master breast pathology, categorize lesions by their **Relative Risk (RR)** for invasive cancer: 1. **No Increased Risk (RR 1.0):** Fibrosis, simple cysts, apocrine metaplasia, duct ectasia, mild hyperplasia, and fibroadenoma (without complex features). 2. **Slightly Increased Risk (RR 1.5–2.0):** Proliferative disease without atypia—includes **Sclerosing adenosis**, radial scar, small duct papillomas, and moderate/florid hyperplasia [1]. 3. **Moderately Increased Risk (RR 4.0–5.0):** Atypical Hyperplasia (Atypical Ductal Hyperplasia [ADH] or Atypical Lobular Hyperplasia [ALH]). 4. **Highest Risk (RR 8.0–10.0):** Carcinoma in situ (DCIS or LCIS). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, pp. 1052-1054. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 446-447.
Question 52: Serum alpha-fetoprotein level is elevated in which of the following conditions?
- A. Endodermal sinus tumor (Correct Answer)
- B. Immature teratoma
- C. Choriocarcinoma
- D. Dysgerminoma
Explanation: **Explanation:** The correct answer is **Endodermal Sinus Tumor (Yolk Sac Tumor)**. This is because the tumor is derived from the extraembryonic yolk sac, which is the physiological site of **Alpha-Fetoprotein (AFP)** synthesis during fetal development [1]. Consequently, AFP serves as a highly specific and sensitive serum biomarker for the diagnosis and monitoring of this malignancy. **Analysis of Options:** * **Endodermal Sinus Tumor (A):** Characterized histologically by **Schiller-Duval bodies** (glomeruloid structures). It is the most common germ cell tumor in children and consistently presents with markedly elevated AFP levels [1]. * **Immature Teratoma (B):** These tumors are composed of tissues from all three germ layers (ectoderm, endoderm, mesoderm) in varying stages of immaturity (typically neuroepithelium). While they may occasionally show mild AFP elevation if yolk sac elements are present, it is not their primary diagnostic marker. * **Choriocarcinoma (C):** This is a highly malignant tumor of trophoblastic cells. The characteristic marker is **beta-hCG**, not AFP. * **Dysgerminoma (D):** This is the female counterpart of the male seminoma. It is typically associated with elevated **LDH** (Lactic Dehydrogenase) and sometimes placental alkaline phosphatase (PLAP), but AFP remains normal. **High-Yield NEET-PG Pearls:** 1. **Schiller-Duval bodies** are pathognomonic for Yolk Sac Tumors [1]. 2. **Reinke crystals** are characteristic of Leydig cell tumors. 3. **Call-Exner bodies** are seen in Granulosa cell tumors (Marker: **Inhibin**). 4. **Psammoma bodies** are found in Serous cystadenocarcinoma. 5. **Summary of Markers:** * Yolk Sac Tumor: AFP * Choriocarcinoma: beta-hCG * Dysgerminoma: LDH * Granulosa Cell Tumor: Inhibin **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 979-980.
Question 53: Which virus is associated with cancer of the cervix?
- A. Human Papillomavirus (HPV) (Correct Answer)
- B. Human Immunodeficiency Virus (HIV)
- C. Epstein-Barr Virus (EBV)
- D. Human T-lymphotropic Virus (HTLV)
Explanation: **Explanation:** **1. Why Human Papillomavirus (HPV) is correct:** HPV is the primary etiological agent for cervical cancer, identified in over 99% of cases [1]. The oncogenic potential lies in the high-risk strains (primarily **HPV 16 and 18**) [1]. These viruses integrate into the host genome, leading to the overexpression of two key oncoproteins [2]: * **E6:** Binds to and degrades the **p53** tumor suppressor protein [4]. * **E7:** Binds to and inactivates the **Retinoblastoma (Rb)** protein [2]. The loss of these cell cycle regulators leads to unchecked cellular proliferation and malignant transformation at the transformation zone of the cervix [4]. **2. Why other options are incorrect:** * **HIV:** While HIV increases the risk of cervical cancer by causing immunosuppression (allowing HPV to persist), it is not the direct causative agent [3]. Cervical cancer is an AIDS-defining illness [3]. * **EBV:** Associated with Burkitt lymphoma, Nasopharyngeal carcinoma, and Hodgkin lymphoma, but not cervical cancer [1]. * **HTLV:** Specifically HTLV-1 is associated with Adult T-cell Leukemia/Lymphoma (ATLL) and tropical spastic paraparesis [1]. **3. NEET-PG High-Yield Clinical Pearls:** * **High-risk strains:** 16 (most common for Squamous Cell Ca) and 18 (highest association with Adenocarcinoma) [1]. * **Low-risk strains:** 6 and 11 (cause Condyloma acuminatum/genital warts) [1]. * **Screening:** Pap smear looks for **koilocytes** (cells with perinuclear halo and wrinkled "raisinoid" nuclei). * **Vaccination:** The quadrivalent vaccine (Gardasil) targets types 6, 11, 16, and 18 [2]. The most effective time for administration is before the first sexual exposure (ages 9–14). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 219-220. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 334-335. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 261-262. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1006-1007.
Question 54: Fibrocystic disease of the breast is associated with which hormonal imbalance?
- A. Estrogen (Correct Answer)
- B. Progesterone
- C. Luteinizing hormone (LH)
- D. Testosterone
Explanation: **Explanation:** **Fibrocystic disease (FCD)**, also known as fibrocystic changes, is the most common benign condition of the female breast [3]. The underlying pathophysiology is primarily driven by an **excess of estrogen** relative to progesterone [1], [3]. 1. **Why Estrogen is Correct:** Estrogen promotes the proliferation of connective tissue and the ductal epithelium of the breast [1]. In FCD, there is typically absolute or relative hyperestrogenism [3]. This hormonal imbalance leads to the characteristic triad of fibrosis, cyst formation, and epithelial hyperplasia [4]. The condition often fluctuates with the menstrual cycle, typically worsening during the luteal phase when hormonal stimulation is peak, and usually regresses after menopause [2], [3]. 2. **Why Incorrect Options are Wrong:** * **Progesterone:** While progesterone is involved in the menstrual cycle, FCD is associated with a **deficiency** or lack of progesterone to counteract the proliferative effects of estrogen, rather than an excess [1]. * **LH (Luteinizing Hormone):** LH triggers ovulation and the formation of the corpus luteum. While it influences the cycle, it does not have a direct stimulatory effect on breast tissue architecture. * **Testosterone:** Androgens generally have an inhibitory effect on breast tissue proliferation; high levels are not associated with fibrocystic changes. **High-Yield Clinical Pearls for NEET-PG:** * **Morphological Hallmarks:** Cysts (often "blue-domed cysts"), fibrosis, and adenosis [4]. * **Risk of Carcinoma:** Most fibrocystic changes (fibrosis, cysts, apocrine metaplasia) carry **no increased risk** of cancer. However, **Atypical Hyperplasia** (ductal or lobular) increases the risk by 4–5 times. * **Sclerosing Adenosis:** Characterized by increased acini and stromal fibrosis; it can mimic carcinoma mammographically due to calcifications. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 451-452. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 442-443. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 445-446. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 439-442.
Question 55: A 22-year-old man complains about his inability to conceive a child. On physical examination, the patient is noted to be tall (6 ft, 5 in) and exhibits gynecomastia and testicular atrophy. Laboratory studies demonstrate increased serum levels of follicle-stimulating hormone. Cytogenetic studies reveal a chromosomal abnormality. What is the most common cause of this patient's chromosomal abnormality?
- A. Expansion of a trinucleotide repeat
- B. Isochromosome formation
- C. Meiotic nondisjunction (Correct Answer)
- D. Nonreciprocal translocation
Explanation: **Explanation:** The clinical presentation of a tall male with gynecomastia, testicular atrophy, and infertility, coupled with elevated FSH, is a classic description of **Klinefelter Syndrome (47, XXY)** [1]. **Why Meiotic Nondisjunction is Correct:** The most common cause of Klinefelter Syndrome (approximately 90% of cases) is **meiotic nondisjunction** during gametogenesis [1]. This occurs when homologous chromosomes (Meiosis I) or sister chromatids (Meiosis II) fail to separate properly. This results in a gamete with an extra X chromosome (XX egg or XY sperm). When fertilized by a normal gamete, the resulting zygote has a 47, XXY karyotype. Maternal age is a known risk factor for this nondisjunction [1]. **Why Other Options are Incorrect:** * **A. Expansion of a trinucleotide repeat:** This is the mechanism for Fragile X syndrome (CGG) or Huntington’s disease (CAG), not aneuploidy. * **B. Isochromosome formation:** This involves the loss of one arm and duplication of the other (e.g., i(Xq) in some Turner syndrome cases), but it is not the primary cause of Klinefelter. * **D. Nonreciprocal translocation:** This involves the transfer of a chromosome segment to a non-homologous chromosome without an exchange; it leads to structural abnormalities, not a gain of a whole sex chromosome. **High-Yield Clinical Pearls for NEET-PG:** * **Karyotype:** Most commonly 47, XXY [1]. * **Hormonal Profile:** Primary hypogonadism (Low Testosterone, **High LH/FSH**, High Estradiol) [2]. * **Histology:** Hyalinization and fibrosis of seminiferous tubules; Leydig cell hyperplasia (pseudohyperplasia). * **Key Risks:** Increased risk of **Male Breast Cancer** (20x higher), Extragonadal Germ Cell Tumors (Mediastinal), and Autoimmune diseases (SLE). * **Barr Body:** Positive (due to the extra X chromosome). * **Stature:** The presence of extra copies of the SHOX gene on the X chromosome contributes to the characteristic tall stature [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 92-93. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 174-175. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 175-177.
Question 56: What is the tumor marker for choriocarcinoma?
- A. HCG (Correct Answer)
- B. AFP
- C. CEA
- D. Desmin
Explanation: **Explanation:** **Choriocarcinoma** is a highly malignant germ cell tumor or gestational trophoblastic neoplasm characterized by the proliferation of **cytotrophoblasts** and **syncytiotrophoblasts** without the formation of chorionic villi [1]. 1. **Why HCG is correct:** Syncytiotrophoblasts are responsible for the synthesis and secretion of **Human Chorionic Gonadotropin (HCG)**. In choriocarcinoma, HCG levels are characteristically markedly elevated [1]. It serves as a definitive marker for diagnosis, monitoring treatment response, and detecting recurrence [1]. 2. **Why the other options are incorrect:** * **AFP (Alpha-Fetoprotein):** This is the marker for **Yolk Sac Tumors** (Endodermal Sinus Tumors) and Hepatocellular Carcinoma. * **CEA (Carcinoembryonic Antigen):** A non-specific marker primarily used for monitoring **colorectal carcinoma** and other adenocarcinomas (pancreas, lung, breast). * **Desmin:** An intermediate filament used as an immunohistochemical marker for **muscle-derived tumors** (e.g., Rhabdomyosarcoma or Leiomyosarcoma), not germ cell tumors. **High-Yield Clinical Pearls for NEET-PG:** * **Hematogenous Spread:** Choriocarcinoma is notorious for early hematogenous spread, most commonly to the **lungs** (presenting as "cannonball metastases" on X-ray). * **Histology:** Look for a "dimorphic" population of cells (syncytiotrophoblasts and cytotrophoblasts) with extensive **hemorrhage and necrosis**, but an absolute **absence of villi** [1]. * **Response to Therapy:** Gestational choriocarcinoma (following pregnancy) has an excellent prognosis with chemotherapy (Methotrexate), whereas non-gestational (ovarian/testicular) choriocarcinoma is more resistant [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1035-1036.
Question 57: Struma ovarii is composed entirely of what tissue?
- A. Mature thyroid tissue (Correct Answer)
- B. Immature thyroid tissue
- C. Primary ovarian carcinoid tissue
- D. None of the above
Explanation: **Explanation:** **Struma ovarii** is a highly specialized or monodermal form of a **mature cystic teratoma** (dermoid cyst) [2]. While typical teratomas contain tissues from all three germ layers [1], struma ovarii is defined by the presence of thyroid tissue as the predominant or exclusive component (comprising >50% of the tumor) [2]. * **Why Option A is correct:** The thyroid tissue found in struma ovarii is histologically **mature**, consisting of follicles filled with colloid, identical to a normal thyroid gland [2]. It is functional tissue that can synthesize thyroid hormones. * **Why Option B is incorrect:** Immature tissue (like primitive neuroepithelium) is a hallmark of **Immature Teratomas**, which are malignant [1]. Struma ovarii consists of well-differentiated, benign mature tissue [2]. * **Why Option C is incorrect:** Primary ovarian carcinoid is another type of monodermal teratoma [2]. While it can sometimes arise within a struma ovarii (forming a "Strumal Carcinoid"), the term "Struma ovarii" specifically refers to the thyroid component [2]. **High-Yield Clinical Pearls for NEET-PG:** 1. **Hyperthyroidism:** Approximately 5–10% of patients present with clinical features of thyrotoxicosis due to ectopic hormone production [2]. 2. **Imaging:** On MRI/CT, it often appears as a multicystic mass with "high-density" areas representing thick colloid. 3. **Ascites:** Interestingly, struma ovarii can present with ascites (and rarely Meigs' syndrome), mimicking ovarian malignancy. 4. **Malignancy:** Although rare, papillary or follicular thyroid carcinoma can arise within a struma ovarii [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1033-1034. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, p. 1034.
Question 58: Infertility in Kallmann syndrome is due to?
- A. Oligospermia
- B. Blockage of epididymis
- C. Asthenospermia (Correct Answer)
- D. Undescended testis
Explanation: **Explanation:** Kallmann syndrome is a form of **hypogonadotropic hypogonadism** caused by the failure of GnRH-secreting neurons to migrate from the olfactory placode to the hypothalamus. This results in a deficiency of GnRH, leading to low levels of FSH and LH. **Why Asthenospermia is correct:** In Kallmann syndrome, the profound deficiency of FSH and LH leads to impaired spermatogenesis. While the total sperm count is often reduced, the most characteristic finding in these patients (and the primary cause of infertility) is **asthenospermia** (reduced sperm motility) and poor sperm quality. This occurs because the maturation of spermatozoa and the secretory function of accessory sex glands (which provide the medium for motility) are highly dependent on the androgenic environment created by LH and FSH. **Analysis of Incorrect Options:** * **Oligospermia:** While sperm count is low, "Asthenospermia" is the more specific finding associated with the hormonal milieu of hypogonadotropic hypogonadism in clinical examinations. * **Blockage of epididymis:** This is a cause of obstructive azoospermia (e.g., in Cystic Fibrosis or post-inflammatory states). Kallmann syndrome is a pre-testicular, hormonal cause of infertility, not an obstructive one. * **Undescended testis (Cryptorchidism):** While cryptorchidism can be associated with Kallmann syndrome due to low fetal gonadotropins, it is a developmental anatomical defect, not the primary physiological mechanism of infertility in the adult presentation. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad:** Hypogonadotropic hypogonadism + Anosmia/Hyposmia + Midline defects (e.g., cleft lip/palate). * **Genetics:** Most commonly due to a mutation in the **KAL-1 gene** (X-linked recessive), which codes for the protein anosmin-1. * **MRI Finding:** Absence or hypoplasia of the **olfactory bulbs**. * **Treatment:** Pulsatile GnRH therapy or gonadotropin replacement (hCG/hMG) can often restore fertility.
Question 59: A 29-year-old female presents with severe pain during menstruation (dysmenorrhea). During workup, an endometrial biopsy is obtained. The pathology report from this specimen makes the diagnosis of chronic endometritis. Based on this pathology report, which one of the following was present in the biopsy sample of the endometrium?
- A. Neutrophils
- B. Lymphocytes
- C. Lymphoid follicles
- D. Plasma cells (Correct Answer)
Explanation: ### Explanation **1. Why Plasma Cells are the Correct Answer:** In pathology, the gold standard for the diagnosis of **chronic endometritis** is the identification of **plasma cells** within the endometrial stroma [1]. While other inflammatory cells like lymphocytes and macrophages are commonly found in the normal endometrium during various phases of the menstrual cycle, plasma cells are **never** present in a healthy endometrium. Their presence is pathognomonic (diagnostic) for chronic inflammation of the uterine lining. **2. Analysis of Incorrect Options:** * **A. Neutrophils:** These are the hallmark of **acute inflammation**. While they may be seen in acute endometritis (often post-partum or post-abortion), they do not define the chronic form. * **B. Lymphocytes:** These are frequently found in the normal endometrium, especially during the late secretory phase. Therefore, their presence alone is non-specific and insufficient to diagnose chronic endometritis. * **C. Lymphoid follicles:** While lymphoid follicles with germinal centers can be seen in severe or long-standing cases of chronic endometritis (sometimes called "follicular endometritis"), they are not the primary diagnostic requirement. The presence of plasma cells remains the essential criterion. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Common Causes:** Chronic Pelvic Inflammatory Disease (PID), retained products of conception, intrauterine devices (IUDs), and Tuberculosis (granulomatous endometritis). * **Clinical Presentation:** Often presents with triad of **abnormal uterine bleeding (AUB)**, pelvic pain, and infertility. * **Staining Tip:** If plasma cells are difficult to identify on routine H&E stain (due to stromal condensation), **Syndecan-1 (CD138)** is the specific immunohistochemical marker used to highlight them. * **Association:** Chronic endometritis is a significant cause of **unexplained infertility** and recurrent implantation failure in IVF. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 195-196.
Question 60: Benign condyloma is associated with which condition?
- A. Infection by human papillomavirus (HPV) type 11 (Correct Answer)
- B. Infection by HPV type 16
- C. Infection by HPV type 18
- D. Lichen sclerosus
Explanation: **Explanation:** **Condyloma acuminatum** (genital warts) is a benign papillary lesion of the squamous epithelium, most commonly found on the vulva, penis, or perianal region [1]. 1. **Why Option A is correct:** Condyloma acuminatum is caused by **"low-risk" Human Papillomavirus (HPV) types 6 and 11**. These viruses have low oncogenic potential and typically cause benign proliferations rather than malignancies. The hallmark histological feature is **koilocytosis**—superficial squamous cells with cytoplasmic vacuolation and wrinkled, "raisin-like" nuclei [4]. 2. **Why other options are incorrect:** * **Options B & C (HPV 16 & 18):** These are **"high-risk" HPV types**. They are strongly associated with High-grade Squamous Intraepithelial Lesions (HSIL) and invasive squamous cell carcinomas of the cervix, vulva, and vagina [2]. They integrate their DNA into the host genome, leading to the overexpression of oncoproteins E6 (which inhibits p53) and E7 (which inhibits RB) [3]. * **Option D (Lichen sclerosus):** This is a chronic inflammatory dermatosis characterized by thinning of the epidermis and subepithelial fibrosis (hyalinization). While it carries a small risk of progressing to squamous cell carcinoma, it is not caused by HPV. **High-Yield Clinical Pearls for NEET-PG:** * **HPV 6 & 11:** Associated with Condyloma acuminatum and Laryngeal papillomas. * **HPV 16 & 18:** Associated with Cervical Cancer, Vulvar Intraepithelial Neoplasia (VIN), and Oropharyngeal cancer. * **Koilocytes:** Pathognomonic for HPV infection; seen in both benign condylomas and pre-malignant lesions [1]. * **Vaccination:** The quadrivalent HPV vaccine (Gardasil) protects against types 6, 11, 16, and 18. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Female Genital Tract Disease, pp. 466-467. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1006-1007. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1007-1008. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Skin, pp. 1177-1178.
Practice by Chapter
Diseases of Male Genital Tract
Practice Questions
Testicular Tumors
Practice Questions
Prostate Pathology
Practice Questions
Diseases of Female Genital Tract
Practice Questions
Cervical Pathology and Neoplasia
Practice Questions
Endometrial Pathology
Practice Questions
Ovarian Diseases and Tumors
Practice Questions
Gestational Trophoblastic Disease
Practice Questions
Placental Pathology
Practice Questions
Sexually Transmitted Infections
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free